# Nicotinamide Riboside (NR / Tru Niagen) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Oral NAD+ precursor proven in clinical pharmacokinetic trials to safely double circulating human NAD+ pools, fuel sirtuin longevity enzymes, stimulate mitochondrial respiration, and reduce aortic stiffness in older adults.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **92/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 93/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 94/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: moderate
- **Adherence Friction**: 1/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Pivotal Nature Communications human trials confirm high oral bioavailability, robust elevation of whole blood and PBMC NAD+ metabolome, and arterial elasticity improvements in aging cohorts without flushing.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **85/100** [Rank #18 of 133 in Heart] - Effect: Strong (Elevates vascular NAD+, improves endothelial compliance, and reduces aortic stiffness)
    - Mechanism: Recharges endothelial and vascular smooth muscle NAD+ pools, stimulating SIRT1 to deacetylate eNOS and lower aortic pulse wave velocity.
- **Brain Longevity & Neuroprotection**: **90/100** [Rank #16 of 141 in Brain] - Effect: Strong (Boosts cerebral NAD+, stimulates mitochondrial biogenesis, and protects against neurodegeneration)
    - Mechanism: Bypasses the blood-brain barrier to fuel SIRT3 and PGC-1alpha in cortical neurons, preserving synaptic transmission and mitochondrial quality control.
- **Metabolic Flexibility & Glycemic Control**: **88/100** [Rank #15 of 129 in Metabolic] - Effect: Strong (Enhances mitochondrial oxidative phosphorylation and fatty acid beta-oxidation)
    - Mechanism: Elevates cellular NAD+/NADH redox balance, activating sirtuin deacetylation of metabolic transcription factors and mitochondrial enzymes.
- **Cancer Defense & DNA Repair**: **70/100** [Rank #21 of 120 in Cancer Defense] - Effect: Moderate (Fuels PARP1/2 DNA repair while requiring caution in active glycolytic tumors)
    - Mechanism: Supplies essential NAD+ substrate to fuel PARP-mediated DNA repair, maintaining genomic fidelity and suppressing oncogenic mutational accumulation.
- **Endocrine & Anabolic Balance**: **70/100** [Rank #25 of 120 in Endocrine] - Effect: Mild (Supports Leydig cell mitochondrial bioenergetics during aging)
    - Mechanism: Sustains mitochondrial electron transport in testicular steroidogenic enzymes, mitigating age-related decline in steroidogenesis.
- **Chronic Inflammation Reduction**: **86/100** [Rank #23 of 126 in Inflammation] - Effect: Strong (Suppresses NLRP3 inflammasome and downregulates circulating inflammatory markers)
    - Mechanism: Elevated NAD+ activates SIRT2 to deacetylate and inactivate the NLRP3 inflammasome complex, halting pro-inflammatory cytokine secretion.
- **Bone Density & Connective Matrix**: **75/100** [Rank #51 of 142 in Bone Matrix] - Effect: Moderate (Supports osteoblast mitochondrial differentiation and bone matrix deposition)
    - Mechanism: Supports high bioenergetic demands of mineralizing osteoblasts through enhanced mitochondrial ATP generation.
- **Cellular Longevity & Autophagy**: **95/100** [Rank #5 of 131 in Cellular] - Effect: Massive (Restores the master longevity coenzyme NAD+ by up to 2.7-fold across human tissues)
    - Mechanism: Acts as an orally bioavailable precursor that directly replenishes declining intracellular NAD+ pools, powering all seven sirtuins, PARPs, and CD38-mediated cellular maintenance pathways.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: Refer to individualized clinical assessment
- **Recommended Timing**: Consistent daily schedule
- **Administration Type**: Behavioral / Compound
- **Recommended Biomarkers to Monitor**: energy, cellular_longevity, focus, bone_density, heart_health, testosterone

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Active malignant neoplasms with high glycolytic/NAD+ dependency without oncological supervision
- **Safety Profile**: High Margin - Mild nausea or headache in rare cases (<2%); Occasional insomnia if taken late in evening

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **NR Cerebral Microvascular Endothelial Compliance** [PMID: 29599478]
   - Link: https://pubmed.ncbi.nlm.nih.gov/29599478/
2. **Nicotinamide riboside is uniquely and orally bioavailable in mice and humans** [PMID: 27721479]
   - Link: https://pubmed.ncbi.nlm.nih.gov/27721479/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Nicotinamide Riboside (NR / Tru Niagen) on LongevityReviews](https://longevityreviews.org/modalities/nicotinamide-riboside-nr)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.